United Therapeutics Corporation (NASDAQ ... Our latest SEC filings, including Forms 10-Ks and 10-Q, contain additional information on these risks and uncertainties. We assume no obligation to ...

Our latest SEC filings, including Forms 10-Ks and 10-Q ... Operator, you may now wrap up the call. Operator: Thank you for participating in today’s United Therapeutics Corporation Earnings ...

Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ETCompany ParticipantsLaure Park - Senior Vice President ...

Fri 28 Feb: AMP (AMP) – $0.01, Australian United Investment Company (AUI) – $0.17, Carlton Investments (CIN) – $0.45, Centrepoint Alliance (CAF) – $0.013, Codan (CDA) – $0.125, Corporate Travel ...

Market breadth was bearish as 9 out of the 10 index stocks witnessed a decline. The past three months have been a volatile period for NIFTY Realty. In 5 of the past 12 weeks, the index was either ...

Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 10.9% in the afternoon session after the company reported disappointing fourth-quarter results: EPS missed analysts ...

topping the consensus estimate of $6.10 by $0.09. The firm had revenue of $735.90 million for the quarter, compared to analyst estimates of $734.74 million. United Therapeutics had a return on ...

Good morning and welcome to the United Therapeutics Corporation ... Our latest SEC filings, including Forms 10-K and 10-Q, contain additional information on these risks and uncertainties.

Finally, HC Wainwright restated a “buy” rating and set a $425.00 price target on shares of United Therapeutics in a report on Thursday, February 27th. 10 Stocks to Sell NOW! 3 Stocks to DOUBLE ...

For deeper insights into United Therapeutics' valuation and growth metrics, InvestingPro subscribers have access to over 10 additional exclusive financial tips and comprehensive analysis.

Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 10.9% in the afternoon session after the company reported disappointing fourth-quarter results: EPS missed analysts' expectations ...